Cardio Diagnostics Holdings, Inc.(CDIO)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Cardio Diagnostics Holdings, Inc. (CDIO) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CDIO at 4.3/100 on a 32-signal composite quality model, placing it at rank #2,955 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Cardio Diagnostics Holdings, Inc. reports quarterly revenue of $5.4K, net income of $-1.5M, free cash flow of $-1.3M. Top institutional holders of CDIO by reported 13-F value include BOOTHBAY FUND MANAGEMENT, RENAISSANCE TECHNOLOGIES, BlackRock, based on the most recent SEC filings. CDIO trades on the Nasdaq exchange and files with the SEC under CIK 1870144. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CDIO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cardio Diagnostics Holdings, Inc. directly from SEC EDGAR.